Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla
- 16 February 2014
- journal article
- hepatobiliary pancreas
- Published by Springer Nature in European Radiology
- Vol. 24 (5) , 1013-1019
Abstract
The purpose of this study was to evaluate the usefulness of Gd-EOB-DTPA-enhanced 3-T MRI to determine the hepatic functional reserve expressed by the model for end-stage liver disease (MELD) score.Keywords
This publication has 40 references indexed in Scilit:
- Gd-EOB-DTPA-enhanced MR imaging: Evaluation of hepatic enhancement effects in normal and cirrhotic liversEuropean Journal of Radiology, 2011
- Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot studyEuropean Radiology, 2011
- Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patientsEuropean Radiology, 2011
- Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: The role of laboratory factorsJournal of Magnetic Resonance Imaging, 2011
- Liver Functional Reserve Estimation: State of the Art and Relevance to Local TreatmentsOncology, 2010
- Relationship Between Liver Function and Liver Signal Intensity in Hepatobiliary Phase of Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance ImagingJournal of Computer Assisted Tomography, 2010
- The model for end-stage liver disease (MELD)Hepatology, 2007
- Quantitative Evaluation of Liver Function with MRI Using Gd-EOB-DTPAKorean Journal of Radiology, 2004
- Molecular Mechanisms for the Hepatic Uptake of Magnetic Resonance Imaging Contrast AgentsBiochemical and Biophysical Research Communications, 1999
- Mechanism of hepatic uptake of gadoxetate disodiumAcademic Radiology, 1996